NCT05155137View on ClinicalTrials.gov

Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)

PHASE3RecruitingINTERVENTIONAL
Enrollment

8,518

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

December 14, 2029

Study Completion Date

December 14, 2030

Conditions
StrokeCognitive Decline
Interventions
DRUG

Drug Capsule (Valsartan + Amlodipine + Rosuvastatin)

Polypill with 3 medications (Valsartan 80 mg + Amlodipine 5 mg + Rosuvastatin 10 mg)

BEHAVIORAL

Stroke Riskometer

Participants will be randomized to use Stroke Riskometer App for lifestyle modifications

Trial Locations (2)

90620-110

RECRUITING

Unidade de Saúde Santa Cecília / Hospital de Clínicas de Porto Alegre, Porto Alegre

Unknown

RECRUITING

Hospital Moinhos de Vento, Porto Alegre

All Listed Sponsors
collaborator

Ministry of Health, Brazil

OTHER_GOV

collaborator

World Stroke Organization

UNKNOWN

lead

Hospital Moinhos de Vento

OTHER